Welcome to our dedicated page for AdaptHealth news (Ticker: AHCO), a resource for investors and traders seeking the latest updates and insights on AdaptHealth stock.
AdaptHealth Corp. (NASDAQ: AHCO) is a leading provider of patient-centered, healthcare-at-home solutions across the United States. Operating in 47 states, AdaptHealth offers a comprehensive range of home medical equipment (HME) and services to help patients manage chronic conditions and improve their quality of life in the comfort of their homes.
Founded on the principle that everyone deserves a comfortable and independent life, AdaptHealth's offerings include sleep and respiratory therapy, diabetes management supplies, mobility products, wound care, non-invasive ventilation, and nutritional support. Their clinically-focused services assist patients with daily living activities, supporting approximately 4.1 million patients annually through a network of around 670 locations.
The company's core offerings include sleep therapy equipment (including CPAP and biPAP services) for those with obstructive sleep apnea, medical devices for diabetes management (such as continuous glucose monitors and insulin pumps), and oxygen therapy and related chronic care services. Additionally, AdaptHealth provides specialized HME devices and supplies for wound care, urological, incontinence, ostomy, and nutritional needs.
AdaptHealth is renowned for its extensive partnerships with a diverse network of referral sources, including acute care hospitals, sleep labs, pulmonologists, skilled nursing facilities, and clinics. The company serves beneficiaries of Medicare, Medicaid, and commercial insurance payors, making it a cornerstone in the provision of at-home medical care in the U.S.
Despite facing challenges, AdaptHealth has shown remarkable financial resilience and growth. The company reported a net revenue of $793.3 million for the second quarter of 2023, an increase of 9% compared to the same period in 2022. Their adjusted EBITDA reached $171.0 million, up by 14%, showcasing robust financial health and operational efficiency.
Going forward, AdaptHealth continues to focus on enhancing its service offerings and operational efficiency under new leadership. The recent appointment of Suzanne Foster as Chief Executive Officer marks a significant step in the company’s strategic direction, aimed at furthering its mission to deliver high-quality, patient-centered care.
For more detailed financial results and updates, visit AdaptHealth’s official website.
AdaptHealth Corp. (NASDAQ: AHCO) announced new long-term financial goals during its 2022 Capital Markets Day. CEO Steve Griggs highlighted the company's progress in establishing a scalable foundation for profitable growth and shareholder value. The company aims to lead the shift to connected in-home healthcare, emphasizing its commitment to cost-effective patient care. AdaptHealth serves approx. 3.9 million patients annually, leveraging operational excellence and strategic acquisitions. The firm is focused on enhancing its chronic disease management programs and expanding its connected care offerings.
AdaptHealth Corp. (NASDAQ: AHCO) will host its first Capital Markets Day on September 16, 2022, at 9:00 a.m. ET. The event aims to present the Company’s business model, market position, and long-term strategies for growth and profitability. CEO Steve Griggs emphasizes the importance of connecting with investors and analysts. The event will be webcast live, with additional materials available on AdaptHealth’s website. This initiative reflects AdaptHealth's commitment to providing healthcare-at-home solutions and reaching approximately 3.9 million patients annually across the U.S.
AdaptHealth Corp. (NASDAQ: AHCO) reported second-quarter financial results for 2022, highlighting a net revenue of $727.6 million, a 17.9% increase from $617.0 million in 2021. Adjusted EBITDA rose 1.8% to $150.0 million, with an EBITDA margin improvement to 20.6%. However, net income dropped to $14.0 million from $79.1 million year-over-year. Non-acquired net revenue slightly decreased by 0.3%. The company maintained its 2022 guidance, projecting net revenue between $2.840 billion and $3.040 billion.
AdaptHealth Corp. (NASD: AHCO) will be added to the S&P SmallCap 600 index, effective August 4, 2022. This change comes as Cummins Inc. (NYSE: CMI) is acquiring Meritor Inc. (NYSE: MTOR), which is being removed from the index. The transition reflects a strategic reshuffle in the S&P indices as AdaptHealth enhances its presence in the health care sector. The acquisition of Meritor by Cummins is expected to complete soon, pending closing conditions.
AdaptHealth Corp. (NASDAQ: AHCO) will announce its Q2 2022 financial results before market open on
AdaptHealth Corp. (NASDAQ: AHCO) has announced that
AdaptHealth is a leader in providing patient-centered healthcare-at-home solutions, serving approximately 3.9 million patients annually across the United States.
AdaptHealth Corp. (NASDAQ: AHCO) will participate in a fireside chat at the UBS Global Healthcare Conference on May 25, 2022, at 10:00 am ET. President Josh Parnes and CFO Jason Clemens will represent the Company, a leader in patient-centered healthcare-at-home solutions. Interested parties can access a live webcast on AdaptHealth's website. The Company serves around 3.9 million patients annually through over 750 locations nationwide, offering medical equipment and services designed for chronic condition management.
AdaptHealth Corp. (NASDAQ: AHCO) announced participation in a fireside chat at the RBC Capital Markets 2022 Global Healthcare Conference on May 17, 2022, at 10:30 am ET. President Josh Parnes and CFO Jason Clemens will represent the company. A live webcast will be available on AdaptHealth’s website, which should be accessed 5-10 minutes before the session. AdaptHealth is a leader in patient-centered healthcare-at-home solutions, serving approximately 3.9 million patients annually across the U.S.
AdaptHealth Corp. (NASDAQ: AHCO) announced strong financial results for Q1 2022, with net revenue of $706.2 million, a 46.5% increase from the previous year. Adjusted EBITDA rose 32.1% to $137.6 million. The company reported a net income of $41.8 million compared to a net loss of $4.0 million in Q1 2021. A share repurchase program for up to $200 million was authorized, reflecting confidence in the company's outlook. AdaptHealth has continued to address challenges from CPAP equipment shortages and has completed six acquisitions this year, with updated revenue guidance for 2022 between $2.840 billion and $3.040 billion.
AdaptHealth Corp. (NASDAQ: AHCO) announced participation in a fireside chat at the BofA Securities 2022 Healthcare Conference on May 11 at 12:40 pm PT. CEO Steve Griggs and CFO Jason Clemens will lead the discussion, which can be accessed via a live webcast on AdaptHealth's website. The company is a leader in providing patient-centered healthcare-at-home solutions, serving approximately 3.8 million patients annually across the U.S. through over 750 locations. This includes services for chronic conditions like sleep apnea and diabetes.
FAQ
What is the current stock price of AdaptHealth (AHCO)?
What is the market cap of AdaptHealth (AHCO)?
What services does AdaptHealth Corp. provide?
Where does AdaptHealth operate?
What is included in AdaptHealth’s sleep therapy services?
How does AdaptHealth assist patients with diabetes?
What recent financial performance has AdaptHealth reported?
Who is the current CEO of AdaptHealth Corp.?
What kind of equipment does AdaptHealth provide for respiratory therapy?
How does AdaptHealth support wound care?
What partnerships does AdaptHealth have?
How can investors get more information about AdaptHealth?
